- Home
- BLBD vs MNKD Comparison
BLBD vs MNKD Comparison
Compare BLBD & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLBD
- MNKD
- Stock Information
- Founded
- BLBD 1927
- MNKD 1991
- Country
- BLBD United States
- MNKD United States
- Employees
- BLBD N/A
- MNKD N/A
- Industry
- BLBD Construction/Ag Equipment/Trucks
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- BLBD Consumer Discretionary
- MNKD Health Care
- Exchange
- BLBD Nasdaq
- MNKD Nasdaq
- Market Cap
- BLBD 1.1B
- MNKD 1.4B
- IPO Year
- BLBD N/A
- MNKD 2004
- Fundamental
- Price
- BLBD $38.73
- MNKD $4.42
- Analyst Decision
- BLBD Strong Buy
- MNKD Strong Buy
- Analyst Count
- BLBD 7
- MNKD 5
- Target Price
- BLBD $56.79
- MNKD $9.40
- AVG Volume (30 Days)
- BLBD 425.2K
- MNKD 1.9M
- Earning Date
- BLBD 05-07-2025
- MNKD 05-08-2025
- Dividend Yield
- BLBD N/A
- MNKD N/A
- EPS Growth
- BLBD 31.05
- MNKD 228.27
- EPS
- BLBD 3.22
- MNKD 0.10
- Revenue
- BLBD $1,356,302,000.00
- MNKD $297,595,000.00
- Revenue This Year
- BLBD $9.64
- MNKD $14.36
- Revenue Next Year
- BLBD $7.99
- MNKD $13.36
- P/E Ratio
- BLBD $11.79
- MNKD $42.62
- Revenue Growth
- BLBD 7.57
- MNKD 32.50
- 52 Week Low
- BLBD $30.04
- MNKD $4.05
- 52 Week High
- BLBD $59.40
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- BLBD 52.52
- MNKD 48.47
- Support Level
- BLBD $37.68
- MNKD $4.07
- Resistance Level
- BLBD $40.00
- MNKD $4.25
- Average True Range (ATR)
- BLBD 1.11
- MNKD 0.16
- MACD
- BLBD -0.35
- MNKD 0.01
- Stochastic Oscillator
- BLBD 28.07
- MNKD 51.39
About BLBD Blue Bird Corporation
Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.